 SOLANA BEACH, Calif., Sept. 22, 2022 GLOBE NEWSWIRE -- Artelo Biosciences, Inc. Nasdaq: ARTL , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be presenting at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29, 2022 at the Sofitel Hotel in New York City. 